Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-associated macrophage-specific SERPING1 contributes to M1-phenotype transition and suppress colorectal cancer tumorigenesis via NF-κB pathway. | Int J Biol Macromol | 2026 | 41513188 | PubTator, text mining | PubMed |
| Mass Spectrometry Proteomics: A Key to Faster Drug Discovery. | J Med Chem | 2026 | 41433248 | PubTator, text mining | PubMed |
| Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond. | Arterioscler Thromb Vasc Biol | 2026 | 41410053 | PubTator, text mining | PubMed |
| Longitudinal proteomic and autoantibody signatures after mRNA vaccination in healthy individuals. | Vaccine | 2026 | 41313893 | PubTator, text mining | PubMed |
| Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. | Blood Adv | 2026 | 41212999 | PubTator, text mining | PubMed |
| Berotralstat effectiveness and safety in patients with hereditary angioedema with normal C1 inhibitor. | J Allergy Clin Immunol Glob | 2026 | 41180162 | PubTator, text mining | PubMed |
| Population-scale analysis reveals inherited C1-inhibitor deficiency is a polyphenotypic thrombotic disorder. | Blood Adv | 2026 | 41026970 | PubTator, text mining | PubMed |
| Aberrant systemic acute-phase complement responses in conjunction with soluble CR1 attribute to varying grades of dengue disease severity. | Front Immunol | 2025 | 41624861 | PubTator, text mining | PubMed |
| Genome wide association study of a Circadian Imbalance Index in 312,935 European ancestry UK Biobank participants identifies loci related to diabetes, mood and myocardial infarction. | Res Sq | 2025 | 41510233 | PubTator, text mining | PubMed |
| Unveiling novel potential drug targets for lung cancer through Mendelian randomization analysis. | Sci Rep | 2025 | 41436647 | PubTator, text mining | PubMed |
| Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor: A Review. | Clin Transl Allergy | 2025 | 41405015 | PubTator, text mining | PubMed |
| Methylome-wide association studies and epigenetic biomarker development for 133 mass spectrometry-assessed circulating proteins in 14,671 Generation Scotland participants. | Genome Biol | 2025 | 41361833 | PubTator, text mining | PubMed |
| Management of hereditary angioedema with normal C1Inh: a series of 163 French patients. | Orphanet J Rare Dis | 2025 | 41331604 | PubTator, text mining | PubMed |
| A sensitive and specific assay to characterize plasma kallikrein activity in plasma from patients with hereditary angioedema. | World Allergy Organ J | 2025 | 41323125 | PubTator, text mining | PubMed |
| Epigenome-wide DNA methylation profiling reveals risk genes for migraine and its subtypes. | J Headache Pain | 2025 | 41315928 | PubTator, text mining | PubMed |
| Implementation of genetic diagnosis and personalized management of hereditary angioedema in a Chinese regional center: a community case study of three families. | Front Allergy | 2025 | 41312112 | PubTator, text mining | PubMed |
| A genome-wide association study of mass spectrometry proteomics using a nanoparticle enrichment platform. | Nat Genet | 2025 | 41310232 | PubTator, text mining | PubMed |
| Potential Drug Targets for Migraine Identified Through Mendelian Randomization Analysis of the Human Plasma Proteome. | Mol Neurobiol | 2025 | 41288865 | PubTator, text mining | PubMed |
| Potential drug targets for chronic obstructive pulmonary disease in the plasma proteome identified through Mendelian randomization. | BMC Pulm Med | 2025 | 41286868 | PubTator, text mining | PubMed |
| Does C1 esterase inhibitor play a role in post COVID-19 neurological symptoms? A randomized, double-blind, placebo-controlled, crossover, proof-of-concept study. | Front Neurol | 2025 | 41281561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=6